Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer: Robert Friel, Prahlad Singh, Alexis Michas

After serving 12 years as CEO of PerkinElmer, Robert Friel will step down from that position as well as from his role as chairman of the board, effective Dec. 29, 2019. He will continue to serve as an advisor until March 1, 2020. The firm also announced that Prahlad Singh, current president and COO of PerkinElmer, will become CEO on Dec. 30, 2019, and he has been elected a director of the company, effective today. Prior to joining PerkinElmer in 2014, Singh was general manager of GE Healthcare's women's health business.

PerkinElmer also said that Alexis Michas, currently lead director, will serve as non-executive chairman of PerkinElmer's board, starting Dec. 30.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.